AI assistant
Sending…
Dedicare — Major Shareholding Notification 2016
Oct 13, 2016
3149_iss_2016-10-13_08452857-4dff-4dba-8491-317ed4bf3d02.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
Issuer Dedicare AB
Holder
HealthInvest Partners AB
Instrument
| Instrument | Dedicare AB B SE0003909282 | |
|---|---|---|
| Before the transaction | ||
| Shares | 443,882 | |
| Voting rights | 88,776 | |
| Transaction | ||
| Reason for major shareholding notification Buy | ||
| Date | 12/10/2016 | |
| Limit for number of shares | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 495,882 | |
| Directly held voting rights | 99,176 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 5.52 % | |
| Directly held voting rights | 2.91 % | |
| Indirectly held voting rights | 0 % | |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 2.91 % | 495,882 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 2.91 % | 495,882 |
| Group total holdings | ||
| Voting rights 99,176 Percentage of voting rights 2.91 |
||
| Published 13/10/2016 10:51 Contact |
||
| Name Anders Hallberg Phone 084403830 |
Email [email protected] |
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Dedicare
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 28
Interim / Quarterly Report
2026
Apr 28
Annual Report (ESEF)
2026
Apr 15
Annual Report (ESEF)
2026
Apr 15
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 20
Major Shareholding Notification
2026
Mar 17
Interim / Quarterly Report
2026
Feb 6